Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 6370
TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124911(US8759338, 15)
Affinity DataIC50:  9nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124913(US8759338, 17)
Affinity DataIC50:  16nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124898(US8759338, 2)
Affinity DataIC50:  18nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124914(US8759338, 18)
Affinity DataIC50:  18nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124911(US8759338, 15)
Affinity DataIC50:  18nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124911(US8759338, 15)
Affinity DataIC50:  19nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124909(US8759338, 13)
Affinity DataIC50:  20nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124913(US8759338, 17)
Affinity DataIC50:  21nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124914(US8759338, 18)
Affinity DataIC50:  29nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124913(US8759338, 17)
Affinity DataIC50:  31nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124898(US8759338, 2)
Affinity DataIC50:  39nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124909(US8759338, 13)
Affinity DataIC50:  49nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124909(US8759338, 13)
Affinity DataIC50:  53nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124915(US8759338, 19)
Affinity DataIC50:  56nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124900(US8759338, 4)
Affinity DataIC50:  61nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124899(US8759338, 3)
Affinity DataIC50:  67nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124897(US8759338, 1)
Affinity DataIC50:  78nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124898(US8759338, 2)
Affinity DataIC50:  90nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124915(US8759338, 19)
Affinity DataIC50:  95nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124914(US8759338, 18)
Affinity DataIC50:  131nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124912(US8759338, 16)
Affinity DataIC50:  149nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124897(US8759338, 1)
Affinity DataIC50:  152nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124905(US8759338, 9)
Affinity DataIC50:  170nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124910(US8759338, 14)
Affinity DataIC50:  180nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124899(US8759338, 3)
Affinity DataIC50:  184nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124903(US8759338, 7)
Affinity DataIC50:  212nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124899(US8759338, 3)
Affinity DataIC50:  230nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124904(US8759338, 8)
Affinity DataIC50:  246nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124901(US8759338, 5)
Affinity DataIC50:  286nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124901(US8759338, 5)
Affinity DataIC50:  293nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124897(US8759338, 1)
Affinity DataIC50:  392nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124912(US8759338, 16)
Affinity DataIC50:  411nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124902(US8759338, 6)
Affinity DataIC50:  460nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124905(US8759338, 9)
Affinity DataIC50:  465nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124907(US8759338, 11)
Affinity DataIC50:  468nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124905(US8759338, 9)
Affinity DataIC50:  498nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124906(US8759338, 10)
Affinity DataIC50:  502nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124900(US8759338, 4)
Affinity DataIC50:  512nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124900(US8759338, 4)
Affinity DataIC50:  589nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124901(US8759338, 5)
Affinity DataIC50:  796nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124910(US8759338, 14)
Affinity DataIC50:  852nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124910(US8759338, 14)
Affinity DataIC50:  882nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124902(US8759338, 6)
Affinity DataIC50:  1.70E+3nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124912(US8759338, 16)
Affinity DataIC50:  1.90E+3nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124915(US8759338, 19)
Affinity DataIC50:  2.00E+3nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124903(US8759338, 7)
Affinity DataIC50:  2.10E+3nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-3(Human)
Novartis

US Patent
LigandPNGBDBM124902(US8759338, 6)
Affinity DataIC50:  2.10E+3nMpH: 7.5Assay Description:The activity of PIM3 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124904(US8759338, 8)
Affinity DataIC50:  2.30E+3nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-2(Human)
Novartis

US Patent
LigandPNGBDBM124904(US8759338, 8)
Affinity DataIC50:  2.50E+3nMpH: 7.5Assay Description:The activity of PIM2 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSerine/threonine-protein kinase pim-1(Human)
Novartis

US Patent
LigandPNGBDBM124907(US8759338, 11)
Affinity DataIC50:  2.90E+3nMpH: 7.5Assay Description:The activity of PIM1 is measured using a luciferase-luciferin based ATP detection reagent to quantify ATP depletion resulting from kinase-catalyzed p...More data for this Ligand-Target Pair
In DepthDetails US Patent


Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: